Popular GLP-1 medications include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Tirzepatide (Mounjaro, Zepbound) Dulaglutide (Trulicity) Exenatide (Byetta) These medications were first approved to treat type 2 diabetes but are now also used to help people with obesity lose weight
Factors such as diabetes, obesity, fertility history, previous pregnancy complications, and overall health can all influence the best path forward
Like Semaglutide, Tirzepatide was engineered for a long half-life, making a weekly injection schedule both possible and ideal
Retatrutide, with its glucagon component that increases energy expenditure, may theoretically influence energy levels differently, but clinical trial data on subjective energy has not yet been published in detail